Amgen to buy Horizon Therapeutics for $28 billion cash

[ad_1] Amgen, which has R&D operations in South San Francisco and has been an opportunistic buyer of Bay Area drug developers, has emerged as the winner of a competition to buy Horizon.

[ad_2]

Share this news on your Fb,Twitter and Whatsapp

File source

Times News Network:Latest News Headlines
Times News Network||Health||New York||USA News||Technology||World News